Racial Differences in Erythropoietin Responsiveness

American Journal of Kidney Diseases

Volumn 52, Issue 6, 2008, Pages 1035-1038

  Kaufman, James S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

AFRICAN AMERICAN; CHRONIC KIDNEY DISEASE; COMORBIDITY; EDITORIAL; HEALTH CARE; HEALTH CARE POLICY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HOSPITALIZATION; HUMAN; HYPERPARATHYROIDISM; INFECTION; INFLAMMATION; IRON DEFICIENCY; LEUKOCYTE COUNT; PARATHYROID HORMONE BLOOD LEVEL; PRACTICE GUIDELINE; RACE DIFFERENCE; REIMBURSEMENT; SOCIOECONOMICS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

AFRICAN AMERICANS; ANEMIA; CHRONIC DISEASE; EPOETIN ALFA; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEMATINICS; HUMANS; KIDNEY DISEASES;

EID: 56049092003     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.10.002     Document Type: Editorial

References (19)

1. Kausz A.T., Solid C., Pereira B.J., Collins A.J., and St. Peter W. Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease. Am J Kidney Dis 45 (2005) 136-147
2. Petronis K., Carroll C., Held P., and Port F. Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA 271 (1994) 1760-1763
3. Tomson C., Edmunds M., Chambers K., Bricknell S., Feehally J., and Walls J. Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anemia and renal failure. Nephrol Dial Transplant 7 (1992) 817-821
4. Lacson E., Rogus J., Teng M., and Lazarus J.M. Hakim RH: The association of race with eryhtropoietin dose in patients on long-term hemodialysis. Am J Kidney Dis 52 (2008) 1104-1114
5. Beutler E., and West C. Hematologic differences between African-Americans and whites: the role of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 106 (2005) 740-745
6. Foley R.N., Wang C., Ishani A., and Collins A.J. NHANES III: Influence of race on GFR thresholds and detection of metabolic abnormalities. J Am Soc Nephrol 18 (2007) 2575-2582
7. McFarlane S.I., Chen S.C., Whaley-Connell A.T., et al. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 4 suppl 2 (2008) S45-S55
8. Collins A.J., Li S., St. Peter W., et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 12 (2001) 2465-2473
9. Ma J.Z., Ebben J., Xia H., and Collins A.J. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10 (1999) 610-619
10. Madore F., Lowrie E.G., Brugnara C., et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 8 (1997) 1921-1929
11. Besarab A., Bolton W.K., Browne J.K., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 (1998) 584-590
12. Drueke T.B., Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 (2006) 2071-2084
13. Foley R.N., Parfrey P.S., Morgan J., et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58 (2000) 1325-1335
14. Parfrey P.S., Foley R.N., Wittreich B.H., et al. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16 (2005) 2180-2189
15. Phrommintikul A., Haas S.J., Elsik M., and Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369 (2007) 381-388
16. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 (2006) 2085-2098
17. Zhang Y., Thamer M., Stefanik K., Kaufman J., and Cotter D.J. Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 44 (2004) 866-876
18. Szczech L.A., Barnhart H.X., Inrig J.K., et al. Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 74 (2008) 791-798
19. Norris K., Mehrotra R., and Nissenson A.R. Racial differences in mortality and ESRD. Am J Kidney Dis 52 (2008) 205-208